March 2018 HPV Vaccination Supplement

The Path Ahead for the HPV Vaccine

March 02, 2018

Special Section: Immunizations & Vaccinations

The question of whether a state has the right to institute a mandatory vaccination policy against human papillomavirus (HPV) for school children remains hotly disputed.

Making HPV Vaccination Affordable for Patients

March 02, 2018

Special Section: Immunizations & Vaccinations

Human papillomavirus infection (HPV) is a known cause for virtually all cases of cervical and anal cancers and about 70% of oropharyngeal cancer cases.

Year-Round Solutions Beyond the Influenza Season

March 02, 2018

Special Section: Immunizations & Vaccinations

As the margin between acquisition cost and sales price continues to narrow for traditional community pharmacy medication dispensing, many pharmacies are increasingly turning to service-based opportunities to improve their profitability.

Dialogue and Education: Engaging Young Adults on the HPV Vaccine

March 02, 2018

Special Section: Immunizations & Vaccinations

Vaccinations are often given to protect populations whose immune systems are most vulnerable, but pharmacists are aware that some vaccinations are also important during the adolescent and young-adult years.

The 9-Valent HPV Recombinant Vaccine: An Introduction

March 01, 2018

Special Section: Immunizations & Vaccinations

The 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil 9, Merck & Company, Inc.) is indicated for women and men aged 9 to 26 years for the prevention of certain diseases, precancerous lesions, and genital warts caused by HPV.